Changes in cardiovascular responses of conscious rats to endogenous opioids following treatment with catecholamine-depleting agents.
Dixon
W R
WR
Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence 66045.
Chang
P L
PL
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002320:Cardiovascular Physiological Phenomena; D002395:Catecholamines / Q000037:antagonists & inhibitors* / Q000097:blood; D004399:Dynorphins / Q000494:pharmacology; D004723:Endorphins / Q000502:physiology*; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D009043:Motor Activity; D009270:Naloxone / Q000494:pharmacology; D009294:Narcotics; D009498:Neurotoxins; D016627:Oxidopamine; D010446:Peptide Fragments / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D002395:Catecholamines; D004723:Endorphins; D006892:Hydroxydopamines; D009294:Narcotics; D009498:Neurotoxins; D010446:Peptide Fragments; D009270:Naloxone; D004744:Enkephalin, Methionine; C022118:enkephalinamide-Met, Ala(2)-; C026843:dynorphin (1-13); D004399:Dynorphins; D001285:Atropine; D012110:Reserpine; D016627:Oxidopamine; D014700:Verapamil